PGx Study to Develop and Validate the Predictive Warfarin Dosing Algorithm for Personalized Warfarin Pharmacotherapy

Warfarin Dosing Algorithm for Personalized Warfarin Pharmacotherapy in Korean Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01178502

Enrollment

405

Registered

2010-08-10

Start date

2008-03-31

Completion date

2010-04-30

Last updated

2013-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Valve Diseases

Brief summary

To develop and validate the predictive warfarin dosing algorithm.

Detailed description

This study aims to develop and validate the predictive warfarin dosing algorithm for personalized warfarin pharmacotherapy in Korean patients.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* the patients taking warfarin

Exclusion criteria

* noncompliance

Design outcomes

Primary

Measure	Time frame
To Develop and Validate the Predictive Warfarin Dosing Algorithm	1 year

Countries

South Korea

Outcome results